Nea Management Company, LLC Cti Biopharma Corp Transaction History

Nea Management Company, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$5.36 - $7.43 $23.4 Million - $32.4 Million	-4,361,545 Reduced 54.2%	3,685,683 $21.5 Million
Q2 2022 Aug 15, 2022	BUY	$3.55 - $6.27 $3.22 Million - $5.69 Million	906,778 Added 12.7%	8,047,228 $48 Million
Q1 2020 May 06, 2020	BUY	$0.69 - $1.54 $2.34 Million - $5.22 Million	3,390,450 Added 90.41%	7,140,450 $6.57 Million
Q1 2018 May 10, 2018	BUY	$2.7 - $4.06 $10.1 Million - $15.2 Million	3,750,000 New	3,750,000 $14.6 Million

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Nea Management Company, LLC with notifications on news.